Cite
Yang YS, Chin YT, Hsieh MT, et al. Correction: Novel leptin OB3 peptide-induced signaling and progression in thyroid cancers: Comparison with leptin. Oncotarget. 2017;8(21):35480doi: 10.18632/oncotarget.18067.
Yang, Y. S., Chin, Y. T., Hsieh, M. T., Lai, H. Y., Ke, C. C., Crawford, D. R., Lee, O. K., Fu, E., Mousa, S. A., Grasso, P., Liu, L. F., Chang, H. Y., Tang, H. Y., Lin, H. Y., & Davis, P. J. (2017). Correction: Novel leptin OB3 peptide-induced signaling and progression in thyroid cancers: Comparison with leptin. Oncotarget, 8(21), 35480. https://doi.org/10.18632/oncotarget.18067
Yang, Yu-Chen Sh, et al. "Correction: Novel leptin OB3 peptide-induced signaling and progression in thyroid cancers: Comparison with leptin." Oncotarget vol. 8,21 (2017): 35480. doi: https://doi.org/10.18632/oncotarget.18067
Yang YS, Chin YT, Hsieh MT, Lai HY, Ke CC, Crawford DR, Lee OK, Fu E, Mousa SA, Grasso P, Liu LF, Chang HY, Tang HY, Lin HY, Davis PJ. Correction: Novel leptin OB3 peptide-induced signaling and progression in thyroid cancers: Comparison with leptin. Oncotarget. 2017 May 23;8(21):35480. doi: 10.18632/oncotarget.18067. PMID: 28545220; PMCID: PMC5471071.
Copy
Download .nbib
